back to Directory

Deep Longevity (acquired by Regent Pacific Group)

Deep Longevity logo

Founded
2020
Patents
1
Publications
15

Technologies

AI Companies (Drug Discovery) Aging Research

Deep Longevity is developing explainable artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. It is also developing systems for the emerging field of longevity medicine enabling physicians to make better decisions on the interventions that may slow down, or reverse the aging processes. Deep Longevity developed Longevity as a Service (LaaS)© solution to integrate multiple deep biomarkers of aging dubbed “deep aging clocks” to provide a universal multifactorial measure of human biological age.

aging clocks aging biomarkers deep aging clocks


Posts Mentioning This Company

Key Trends in Aging Research: Where Are We Now?

  
Over the past decade, aging research has transitioned from foundational biological studies, including a landmark introduction of 9 hallmarks of aging back in 2013 and its expanded version of 12 hallmarks in 2023, to a highly technical, multidisciplinary field. This transformation has been driven by a lot of advances in …